Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-27RAPP144Third Rock Ventures V, L.P. plan to sell securities of Rapport Therapeutics, Inc. under Form 144MEDIUM
Third Rock Ventures V, L.P. filed Form 144 to notify SEC of plan to sell 18572 units of Rapport Therapeutics, Inc. securities around 2026-05-26, with aggregate market value of $742,880.00. The total outstanding units is 47826929.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transa...
Small CapBiotechnology
2026-05-27KALV144CHRISTOPHER M YEA plan to sell securities of KalVista Pharmaceuticals, Inc. under Form 144MEDIUM
CHRISTOPHER M YEA filed Form 144 to notify SEC of plan to sell 33800 units of KalVista Pharmaceuticals, Inc. securities around 2026-05-27, with aggregate market value of $905,224.84. The total outstanding units is 53240888.0. The amount planned to be sold represents 0.06% of total outstanding units; Recent transactions...
Small CapBiotechnology
2026-05-27EQ144Zedelmayer Christine plan to sell securities of Equillium, Inc. under Form 144MEDIUM
Zedelmayer Christine filed Form 144 to notify SEC of plan to sell 65625 units of Equillium, Inc. securities around 2026-05-27, with aggregate market value of $172,593.00. The total outstanding units is 63226556.0. The amount planned to be sold represents 0.10% of total outstanding units; Recent transactions in past 3 m...
Micro CapBiotechnology